Importantly, mGluR2/3 agonists also seem to be effective in preventing certain aspects of cognitive impairment [14], [51], [73]–[77] although studies of mGluR2/3 agonists in animal models have not produced concrete evidence of cognitive benefit [67], [78]. Here, GRM2 is linked to Cognitive impairment.